1. Home
  2. AVR vs MNSB Comparison

AVR vs MNSB Comparison

Compare AVR & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVR
  • MNSB
  • Stock Information
  • Founded
  • AVR 1999
  • MNSB 2003
  • Country
  • AVR Australia
  • MNSB United States
  • Employees
  • AVR N/A
  • MNSB N/A
  • Industry
  • AVR
  • MNSB Major Banks
  • Sector
  • AVR
  • MNSB Finance
  • Exchange
  • AVR NYSE
  • MNSB Nasdaq
  • Market Cap
  • AVR 162.1M
  • MNSB 140.7M
  • IPO Year
  • AVR 2024
  • MNSB N/A
  • Fundamental
  • Price
  • AVR $3.72
  • MNSB $19.02
  • Analyst Decision
  • AVR Strong Buy
  • MNSB
  • Analyst Count
  • AVR 4
  • MNSB 0
  • Target Price
  • AVR $16.50
  • MNSB N/A
  • AVG Volume (30 Days)
  • AVR 287.9K
  • MNSB 65.2K
  • Earning Date
  • AVR 08-16-2025
  • MNSB 07-28-2025
  • Dividend Yield
  • AVR N/A
  • MNSB 2.12%
  • EPS Growth
  • AVR N/A
  • MNSB N/A
  • EPS
  • AVR N/A
  • MNSB N/A
  • Revenue
  • AVR $2,493,000.00
  • MNSB $59,896,000.00
  • Revenue This Year
  • AVR $25.79
  • MNSB $17.95
  • Revenue Next Year
  • AVR $211.91
  • MNSB $2.52
  • P/E Ratio
  • AVR N/A
  • MNSB N/A
  • Revenue Growth
  • AVR N/A
  • MNSB N/A
  • 52 Week Low
  • AVR $2.34
  • MNSB $15.00
  • 52 Week High
  • AVR $8.79
  • MNSB $20.88
  • Technical
  • Relative Strength Index (RSI)
  • AVR N/A
  • MNSB 55.47
  • Support Level
  • AVR N/A
  • MNSB $18.58
  • Resistance Level
  • AVR N/A
  • MNSB $19.09
  • Average True Range (ATR)
  • AVR 0.00
  • MNSB 0.31
  • MACD
  • AVR 0.00
  • MNSB 0.06
  • Stochastic Oscillator
  • AVR 0.00
  • MNSB 75.69

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: